Novel Platforms in Ocular Drug Delivery workshop discussed at Ophthalmic Drugs

SMi presents the 4th Annual Ophthalmic Drugs Conference taking place on the 23rd -24th November 2020, in London. SMi are also pleased to announce that they will be hosting a half-day post-conference workshop, Wednesday 25th November 2020 at 08.30 – 12.30. Those who register by the 30th September will save £100 with the early bird discount: http://www.ophthalmicdrugs.com/pharmipr2 Workshop will be on ‘Novel Platforms in Ocular Drug Delivery’. Hosted by Dr. Thakur Raghu Raj Singh, Reader in Pharmaceutics, Queen’s University Belfast. In this workshop, challenges associated with different delivery systems and routes of administration will be explored. The benefits and challenges in the design of long-acting (LA) drug delivery systems will be analysed. In this session there will be a use tangible examples of both ocular and non-ocular LA technologies that have been successfully launched in the market. Finally, it will focus on the design space of LA technologies for small molecules vs biologics and the applicability of devices in the delivery of LA formulations. By attending delegates will learn current unmet medical needs in the treatment of ocular diseases. They will be able to discuss current LA products on the market by analysing both ocular and non-ocular technologies. Also discuss challenges in the design of a LA ocular drug delivery technology for small vs large molecules. Attendees will be able to learn the role of devices in the delivery of LA drug delivery systems and review novel LA technologies under development. About the workshop leader Dr Raj Thakur is a Reader in Pharmaceutics at the School of Pharmacy (SoP), QUB and is the Founder, CTO and Director of Re-Vana Therapeutics. His research interest is in the design and physicochemical characterisation of advanced long-acting biodegradable drug delivery systems including minimally invasive medical devices for localised drug delivery. He is the Chair for Ocular Drug Delivery (OcDD) Focus Group supported by the mission of Controlled Release Society (CRS). He has authored over 160 scientific publications, including 60 full papers, 10 book chapters, five textbooks, several invited talks in national and international conferences and patents. Interested parties can learn more about the workshop and full agenda by visiting: http://www.ophthalmicdrugs.com/pharmipr2 Ophthalmic Drugs Conference 23rd -24th November 2020 #OphthalmicDrugs For exclusive tailored sponsorship packages contact: Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk For media queries please contact Jinna Sidhu hsidhu@smi-online.co.uk or call +44 (0)20 7827 6088. ---End---